140 related articles for article (PubMed ID: 2207454)
1. Late complications after allogeneic bone marrow transplantation for leukaemia.
Kolb HJ; Bender-Götze C
Bone Marrow Transplant; 1990 Aug; 6(2):61-72. PubMed ID: 2207454
[TBL] [Abstract][Full Text] [Related]
2. Malignant diseases after allogeneic bone marrow transplantation: an updated overview.
Socié G; Henry-Amar M; Devergie A; Esperou-Bourdeau H; Ribaud P; Traineau R; Gluckman E
Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S75-7. PubMed ID: 8177721
[TBL] [Abstract][Full Text] [Related]
3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
4. Cancer after bone marrow transplantation. IBMTR and EBMT/EULEP Study Group on Late Effects.
Kolb HJ; Guenther W; Duell T; Socie G; Schaeffer E; Holler E; Schumm M; Horowitz MM; Gale RP; Fliedner TM
Bone Marrow Transplant; 1992; 10 Suppl 1():135-8. PubMed ID: 1521085
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
Vossen J
Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
[TBL] [Abstract][Full Text] [Related]
6. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P
Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
[TBL] [Abstract][Full Text] [Related]
7. Late effects in children after bone marrow transplantation: a review.
Locatelli F; Giorgiani G; Pession A; Bozzola M
Haematologica; 1993; 78(5):319-28. PubMed ID: 8314162
[TBL] [Abstract][Full Text] [Related]
8. Leukaemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anaemia.
Lawler M; Locasciulli A; Longoni D; Schiro R; McCann SR
Bone Marrow Transplant; 2002 Mar; 29(5):453-6. PubMed ID: 11919737
[TBL] [Abstract][Full Text] [Related]
9. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
[TBL] [Abstract][Full Text] [Related]
10. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors.
Hasegawa S; Horibe K; Kawabe T; Kato K; Kojima S; Matsuyama T; Hirabayashi N
Bone Marrow Transplant; 1998 Dec; 22(12):1191-7. PubMed ID: 9894723
[TBL] [Abstract][Full Text] [Related]
11. Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders.
Slavin S; Aker M; Shapira MY; Resnick I; Bitan M; Or R
Clin Transpl; 2003; ():275-82. PubMed ID: 15387119
[TBL] [Abstract][Full Text] [Related]
12. Secondary malignancies after marrow transplantation for leukemia or aplastic anemia.
Witherspoon RP; Deeg HJ; Storb R
Transplant Sci; 1994 Sep; 4(1):33-41. PubMed ID: 7804695
[TBL] [Abstract][Full Text] [Related]
13. Long term effects and quality of life in children and adults after marrow transplantation.
Sanders J; Sullivan K; Witherspoon R; Doney K; Anasetti C; Beatty P; Petersen FB
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():27-9. PubMed ID: 2697434
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used.
Bartsch K; Al-Ali H; Reinhardt A; Franke C; Hudecek M; Kamprad M; Tschiedel S; Cross M; Niederwieser D; Gentilini C
Transplantation; 2009 Jan; 87(2):217-21. PubMed ID: 19155975
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
[TBL] [Abstract][Full Text] [Related]
16. Meningioma in long-term survivors after allogeneic bone marrow transplantation.
Meignin V; Gluckman E; Gambaraelli D; Devergie A; Ramee MP; Janin A; Socié G
Bone Marrow Transplant; 1998 Oct; 22(7):723-4. PubMed ID: 9818703
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases.
Tauchmanovà L; Selleri C; Rosa GD; Pagano L; Orio F; Lombardi G; Rotoli B; Colao A
Cancer; 2002 Sep; 95(5):1076-84. PubMed ID: 12209694
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of late side-effects after bone marrow transplantation in children with leukemia.
Uderzo C; Rovelli A; Meloni G; Balduzzi A; Pezzini C; Colombini A; Adamoli L; Fraschini D; Locasciulli A; Masera G
Bone Marrow Transplant; 1991; 8 Suppl 1():44-6. PubMed ID: 1760638
[No Abstract] [Full Text] [Related]
19. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
[TBL] [Abstract][Full Text] [Related]
20. [Allogeneic hematopoietic stem-cell transplantation for hematological malignancies].
Michallet M; Dhedin N; Michallet AS
Bull Cancer; 2001 Sep; 88(9):908-26. PubMed ID: 11604365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
